Diazoles y triazoles derivados del extracto de aceite de ricino: síntesis, efecto hipoglucémico, potencial antioxidante y actividad antimicrobiana

The ricinoleate triglyceride was extracted from castor-oil seeds grown in Algeria and isolated by catalytically methanolyse to methyl ricinoleate. Six diazole and triazole derivatives of ricinoleic acid were synthesized and characterized: 1,3,4-oxadiazole-5-thione (4); 1,3,4-thiadiazole-5-thione (5); 4-N-amino-1,2,4-triazole-5-thiol (7); 1,2,4-triazole-5-thione (9); 5-amino-1,3,4-oxadiazole (10) and 5-amino-1,3,4-thiadiazole (11). The antibacterial and antifungal screening data of synthesized compounds showed appreciable inhibition and among them, 5, 7 and 8 showed more inhibition on Gram positive Enterococcus faecalis than reference ampiciline; while compounds 1, 7, 8, 10 and 11 showed competitive antifungal effects compared to reference amphotericin B. In addition, all synthesized compounds (1-11) showed competitive antioxidant properties, particularly compounds 7 at 125, 250, 500 and 1000 μg/mL and compounds 4, 5 and 9 at a concentration of 1000 μg/mL. The intermediate compounds 1, 2 and 8 showed anti-α-amylase activity at various concentrations in the range of IC50 = (120.25 ± 1.17 - 130.42 ± 2.48). Oxadiazole 4 showed the best α-amylase inhibition by 78.5% at a concentration of 1000 μg/mL.Los triglicéridos de ricinoleico se extrajeron de semillas de aceite de ricino cultivadas en Argelia y se sintetizó catalíticamente con metanolisis el ricinoleato de metilo. Seis derivados de diazoles y triazoles de ácido ricinoleico se han sintetizado y caracterizado: 1,3,4-oxadiazol-5-tiona (4), 1,3,4-tiadiazol-5-tiona (5), 4-N-amino-1,2,4-triazol-5-tiol (7), 1,2,4-triazol-5-tiona (9), 5-amino-1,3,4-oxadiazol (10) y 5-amino-1,3,4-tiadiazol (11). Los datos de detección antibacteriana y antifúngica de los compuestos sintetizados mostraron una inhibición apreciable, entre ellos, los compuestos 5, 7 y 8 mostraron más inhibición en Enterococcus faecalis Gram positivo que la ampicilina de referencia. Mientras que los compuestos 1, 7, 8, 10 y 11 mostraron una influencia antifúngica competitiva en comparación con la anfotericina de referencia B. Como todos los compuestos sintetizados (1-11) mostraron propiedades antioxidantes competitivas, particularmente los compuestos 7, a 125, 250, 500 y 1000 μg/mL también compuestos 4, 5 y 9 a una concentración de 1000 μg/mL. Los compuestos intermedios 1, 2 y 8 mostraron actividad anti-α-amilasa a diversas concentraciones en el rango de IC50 = (120.25 ± 1.17 - 130.42 ± 2.48). El oxadiazol 4 mostró la mejor inhibición de la α-amilasa en un 78.5% a una concentración de 1000 μg/mL

Localisation nasosinusienne des tumeurs plasmocytaires

Introduction : Les tumeurs plasmocytaires représentent 3 à 4% des tumeurs des cavités naso-sinusiennes. Elles nécessitent un bilan diagnostique spécifique et une prise en charge adéquate. Nous nous proposons d’étudier les particularités diagnostiques et thérapeutiques des plasmocytomes naso-sinusiens. Matériel et méthodes : Notre étude est rétrospective comportant 5 cas de plasmocytomes naso-sinusiens confirmés histologiquement.Résultats : Il s’agit de 3 hommes et 2 femmes âgés de 32 à 77 ans. Le plasmocytome avait une localisation sphénoïdale dans un cas, nasale dans 2 cas, ethmoïdo-nasale dans un cas et naso-maxillaire dans le cas restant. Il s’agissait d’un myélome multiple dans un cas. Trois patients ont eu une radiothérapie. Celle-ci était associée à une chimiothérapie dans le cas du myélome multiple et à une exérèse chirurgicale dans les 2 autres cas La chirurgie a été seule dans un cas. La chimiothérapie exclusive a été proposée dans un cas de plasmocytome localement avancé mais le patient a été perdu de vue. Pour les patients suivis, une seule récidive a été notée à 18 mois.Conclusion : La présentation clinique des plasmocytomes nasosinusiens est aspécifique. Le diagnostic est confirmé par l’histologie. Le pronostic est dominé par la présence ou non d’un myélome multiple et par la taille tumorale. Un suivi prolongé est nécessaire.Mots clés : plasmocytome extramédullaire ; cavités naso-sinusiennes ; radiothérapie ; chirurgie.Introduction: Plasmocytomas represent 3-4% of tumors naso-sinus cavities. Their diagnosis requires a specific investigations and adequate management. We report 5 cases of naso-sinus plasmacytoma and we propose to study their diagnostic and therapeutic characteristics.Materials and methods: Our study is retrospective including 5 cases of naso-sinus plasmacytoma confirmed histologically.Results: There were 3 men and 2 women aged 32 to 77 years. The plasmacytoma had a sphenoidal location in one case, nasal in 2 cases, ethmoid-nasal in one case and naso-maxillary in the remaining case. Multiple myeloma was found in one case. Three patients underwent radiotherapy. This was associated with chemotherapy in multiple myeloma case and surgical resection in 2 cases. Surgery alone was performed in one case. Exclusive chemotherapy was proposed in a case of plasmacytoma locally advanced but the patient was lost sight of. For followed patients, only one recurrence was noted at 18 months.Conclusion: The clinical presentation of sinonasal plasmacytomas is aspecific. The diagnosis is confirmed by histology. The prognosis is dominated by the presence or absence of multiple myeloma and tumor size. Prolonged follow-up is necessary.Keywords : extramedullary plasmacytoma, naso-sinus cavities, radiotherapy ; surgery

Isotopic and velocity distributions of Bi produced in charge-pickup reactions of 208Pb at 1 A GeV

Isotopically resolved cross sections and velocity distributions have been measured in charge-pickup reactions of 1 A GeV 208Pb with proton, deuterium and titanium target. The total and partial charge-pickup cross sections in the reactions 208Pb + 1H and 208Pb + 2H are measured to be the same in the limits of the error bars. A weak increase in the total charge-pickup cross section is seen in the reaction of 208Pb with the titanium target. The measured velocity distributions show different contributions - quasi-elastic scattering and Delta-resonance excitation - to the charge-pickup production. Data on total and partial charge-pickup cross sections from these three reactions are compared with other existing data and also with model calculations based on the coupling of different intra-nuclear cascade codes and an evaporation code.Comment: 20 pages, 12 figures, background information on http://www-w2k.gsi.de/kschmidt

o 002geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma mpac patients in real world across europe

n/

Evaporation residues produced in spallation of 208Pb by protons at 500A MeV

The production cross sections of fragmentation-evaporation residues in the reaction Pb+p at 500A MeV have been measured using the inverse-kinematics method and the FRS spectrometer (GSI). Fragments were identified in nuclear charge using ionisation chambers. The mass identification was performed event-by-event using the B-rho - TOF - Delta-E technique. Although partially-unresolved ionic charge states induced an ambiguity on the mass of some heavy fragments, production rates could be obtained with a high accuracy by systematically accounting for the polluting ionic charge states. The contribution of multiple reactions in the target was subtracted using a new, partly self-consistent code. The isobaric distributions are found to have a shape very close to the one observed in experiments at higher energy. Kinematic properties of the fragments were also measured. The total and the isotopic cross sections, including charge-pickup cross sections, are in good agreement with previous measurements. The data are discussed in the light of previous spallation measurements, especially on lead at 1 GeV

p 167symptoms reported at initial diagnosis of metastatic pancreatic adenocarcinoma m pac in routine clinical practice and variation in frequencies across europe

n/

pd 004baseline characteristics and second line treatment for metastatic pancreatic adenocarcinoma mpac patients receiving first line folfirinox gemcitabine nab paclitaxel or gemcitabine monotherapy in routine clinical practice across europe

n/

Temporal variability of mineral dust in southern Tunisia : analysis of 2 years of PM10 concentration, aerosol optical depth, and meteorology monitoring

International audienceThe south of Tunisia is a region very prone to wind erosion. During the last decades, changes in soil management have led to an increase in wind erosion. In February 2013, a ground-based station dedicated to the monitoring of mineral dust (that can be seen in this region as a proxy of the erosion of soils by wind) was installed at the Institut des Régions Arides (IRA) of Médenine (Tunisia) to document the temporal variability of mineral dust concentrations. This station allows continuous measurements of surface PM10 concentration (TEOM™), aerosol optical depth (CIMEL sunphotometer), and total atmospheric deposition of insoluble dust (CARAGA automatic sampler). The simultaneous monitoring of meteorological parameters (wind speed and direction, relative humidity, air temperature, atmospheric pressure, and precipitations) allows to analyse the factors controlling the variations of mineral dust concentration from the sub-daily to the annual scale. The results from the two first years of measurements of PM10 concentration are presented and discussed. In average on year 2014, PM10 concentration is 56 µg/m3. However, mineral dust concentration highly varies throughout the year: very high PM10 concentrations (up to 1,000 µg/m3 in daily mean) are frequently observed during wintertime and springtime, hardly ever in summer. These episodes of high PM10 concentration (when daily average PM10 concentration is higher than 240 µg/m3) sometimes last several days. By combining local meteorological data, air-masses trajectories, sunphotometer measurements, and satellite imagery, the part of the high PM10 concentration due to local emissions and those linked to an advection of dusty air masses by medium and long range transport from the Sahara desert is quantified

canstem303c trial a phase 3 study of napabucasin napa in combination with 5 fluorouracil 5 fu leucovorin and irinotecan folfiri in adult patients pts with previously treated metastatic colorectal cancer mcrc trial in progress

n/